Kennedy Capital Management LLC Sells 5,823 Shares of Cabot Co. (NYSE:CBT)

Kennedy Capital Management LLC trimmed its holdings in Cabot Co. (NYSE:CBT) by 40.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,573 shares of the specialty chemicals company’s stock after selling 5,823 shares during the quarter. Kennedy Capital Management LLC’s holdings in Cabot were worth $783,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of CBT. Neuberger Berman Group LLC boosted its holdings in Cabot by 1.2% in the 4th quarter. Neuberger Berman Group LLC now owns 18,238 shares of the specialty chemicals company’s stock valued at $1,665,000 after purchasing an additional 212 shares during the period. LSV Asset Management lifted its stake in shares of Cabot by 40.5% in the fourth quarter. LSV Asset Management now owns 136,600 shares of the specialty chemicals company’s stock valued at $12,473,000 after buying an additional 39,400 shares during the period. Capital Fund Management S.A. acquired a new stake in Cabot during the fourth quarter worth about $2,022,000. Raymond James Financial Inc. bought a new position in Cabot during the fourth quarter valued at about $5,057,000. Finally, Advisory Services Network LLC acquired a new position in Cabot in the 4th quarter valued at approximately $625,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently issued reports on the company. StockNews.com cut Cabot from a “buy” rating to a “hold” rating in a research report on Wednesday, April 9th. JPMorgan Chase & Co. dropped their price objective on shares of Cabot from $105.00 to $85.00 and set an “underweight” rating for the company in a research note on Friday, February 21st. UBS Group decreased their target price on shares of Cabot from $93.00 to $83.00 and set a “neutral” rating on the stock in a research report on Monday, April 7th. Finally, Mizuho dropped their price target on shares of Cabot from $122.00 to $110.00 and set an “outperform” rating for the company in a research report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $93.25.

Cabot Stock Down 0.6 %

Shares of NYSE:CBT opened at $78.99 on Tuesday. The company has a market capitalization of $4.28 billion, a PE ratio of 10.49, a P/E/G ratio of 0.74 and a beta of 1.04. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. The company’s fifty day moving average is $83.36 and its 200-day moving average is $95.59. Cabot Co. has a 52 week low of $73.63 and a 52 week high of $117.46.

Cabot (NYSE:CBT) last released its quarterly earnings results on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.02. Cabot had a net margin of 10.60% and a return on equity of 26.79%. Equities research analysts predict that Cabot Co. will post 7.57 earnings per share for the current fiscal year.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.